N
Anbio Biotechnology D
D
NNNN
26.850
USD
0.08
(0.30%)
Market Open
Volume
80
EPS
0
Div Yield
-
P/E
183
Market Cap
1,178,478,720
Title: Anbio Biotechnology
Sector: Healthcare
Industry: Medical Instruments & Supplies
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improvepatient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).